MIR548AB

Across TCGA pan-cancer cohorts, MIR548AB RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR548AB data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR548AB RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548AB expression acts as an unfavorable survival marker.

STAD and THCA are the cancer types where MIR548AB RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.164	0.562	<.001	90	view →
THCA	DFS	Tertile	All	0.049	0.828	<.001	54	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR548AB–STAD (DFS)

Open the STAD breakdown →